Increased interleukin-6 is associated with long COVID-19:a systematic review and meta-analysis

Background Coronavirus disease 2019(COVID-19)can involve persistence,sequelae,and other clinical complications that last weeks to months to evolve into long COVID-19.Exploratory studies have suggested that interleukin-6(IL-6)is related to COVID-19;however,the correlation between IL-6 and long COVID-19 is unknown.We designed a systematic review and meta-analysis to assess the relationship between IL-6 levels and long COVID-19.Methods Databases were systematically searched for articles with data on long COVID-19 and IL-6 levels published before September 2022.A total of 22 published studies were eligible for inclusion following the PRISMA guidelines.Analysis of data was undertaken by using Cochran's Q test and the Higgins I-squared(I2)statistic for heterogeneity.Random-effect meta-analyses were conducted to pool the IL-6 levels of long COVID-19 patients and to compare the differences in IL-6 levels among the long COVID-19,healthy,non-postacute sequelae of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection(non-PASC),and acute COVID-19 populations.The funnel plot and Egger's test were used to assess potential publication bias.Sensitivity analysis was used to test the stability of the results.Results An increase in IL-6 levels was observed after SARS-CoV-2 infection.The pooled estimate of IL-6 revealed a mean value of 20.92 pg/ml(95%CI=9.30–32.54 pg/ml,I2=100%,P<0.01)for long COVID-19 patients.The forest plot showed high levels of IL-6 for long COVID-19 compared with healthy controls(mean difference=9.75 pg/ml,95%CI=5.75–13.75 pg/ml,I2=100%,P<0.00001)and PASC category(mean difference=3.32 pg/ml,95%CI=0.22–6.42 pg/ml,I2=88%,P=0.04).The symmetry of the funnel plots was not obvious,and Egger’s test showed that there was no significant small study effect in all groups.Conclusions This study showed that increased IL-6 correlates with long COVID-19.Such an informative revelation suggests IL-6 as a basic determinant to predict long COVID-19 or at least inform on the“early stage”of long COVID-19.

Towards a global One Health index: a potential assessment tool for One Health performance

Background:A One Health approach has been increasingly mainstreamed by the international community, as it provides for holistic thinking in recognizing the close links and inter-dependence of the health of humans, animals and the environment. However, the dearth of real-world evidence has hampered application of a One Health approach in shaping policies and practice. This study proposes the development of a potential evaluation tool for One Health performance, in order to contribute to the scientific measurement of One Health approach and the identification of gaps where One Health capacity building is most urgently needed.Methods:We describe five steps towards a global One Health index (GOHI), including (i) framework formulation;(ii) indicator selection;(iii) database building;(iv) weight determination;and (v) GOHI scores calculation. A cell-like framework for GOHI is proposed, which comprises an external drivers index (EDI), an intrinsic drivers index (IDI) and a core drivers index (CDI). We construct the indicator scheme for GOHI based on this framework after multiple rounds of panel discussions with our expert advisory committee. A fuzzy analytical hierarchy process is adopted to determine the weights for each of the indicators.Results:The weighted indicator scheme of GOHI comprises three first-level indicators, 13 second-level indicators, and 57 third-level indicators. According to the pilot analysis based on the data from more than 200 countries/territories the GOHI scores overall are far from ideal (the highest score of 65.0 out of a maximum score of 100), and we found considerable variations among different countries/territories (31.8–65.0). The results from the pilot analysis are consistent with the results from a literature review, which suggests that a GOHI as a potential tool for the assessment of One Health performance might be feasible.Conclusions:GOHI—subject to rigorous validation—would represent the world’s first evaluation tool that constructs the conceptual framework from a holistic perspective of One Health. Future application of GOHI might promote a common understanding of a strong One Health approach and provide reference for promoting effective measures to strengthen One Health capacity building. With further adaptations under various scenarios, GOHI, along with its technical protocols and databases, will be updated regularly to address current technical limitations, and capture new knowledge.